Back

Effect of renin-angiotensin system inhibitors in elderly patients with heart failure and reduced ejection fraction

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: New insights into pharmacotherapy for acute heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Yodo Tamaki

Tenri Hospital, Tenri (Japan)

7 More presentations in this session

Presentation thumbnail
Spectrum of heart failure in 16 sub-saharan countries: drugs strategies and 8-year trends (the february study 2016-2023)
Professor I. Diop (Dakar, SN)
Abstract Slides Video
Presentation thumbnail
Combination of diuretics to overcome diuretic resistance in acute heart failure: systematic review and updated network meta-analysis
Doctor I. Girard Cunha Vieira Lima (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
REDUCE-HF: a stronger heart go a long way
Doctor K. Kam (Shatin, HK)
Abstract Slides Video
Presentation thumbnail
Comparing treatment strategies for heart failure: a real-world analysis of adding ARNI or SGLT2i to older GDMT
Doctor P. Amornritvanich (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Rationale and study design of the international randomized control trial MYocarditis THerapy with Steroids: the MYTHS trial
Doctor E. Ammirati (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
New insights into pharmacotherapy for acute heart failure

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Comparative analysis of renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor and mineralocorticoid receptor antagonists in heart failure with mildly reduced ejection fraction
thumbnail
Congress Presentation
Efficacy of sodium-glucose cotransporter 2 inhibitors for super-aged heart failure population
thumbnail
Congress Presentation
Contemporary use of beta-blockers in the outpatient treatment of heart failure with atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources